U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888518) titled 'Multistrain Probiotics Against Bacterial Vaginosis' on Feb. 25.
Brief Summary: The primary aim of the study is to clarify whether and to what extent the consumption of the multistrain probiotic OMNi-BiOTiC(R) FLORA plus+ has a positive effect on the vaginal flora and reduces BV. This is determined using the Nugent score and the blackbird criteria.
In one subgroup, the composition of the vaginal microbiome is analysed using 16S rRNA gene sequencing.
Study Start Date: Dec. 12, 2022
Study Type: INTERVENTIONAL
Condition:
Bacterial Vaginosis (BV)
Intervention:
DIETARY_SUPPLEMENT: OMNi-BiOTiC(R) FLORA plus+
specially selected pro...